摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[4-(1H-[1,2,4]-triazol-1-yl) phenyl]-1-(2-methylbenzyl)-4,6-difluoro-1H-benzo[d]imidazole | 1163729-07-4

中文名称
——
中文别名
——
英文名称
2-[4-(1H-[1,2,4]-triazol-1-yl) phenyl]-1-(2-methylbenzyl)-4,6-difluoro-1H-benzo[d]imidazole
英文别名
4,6-Difluoro-1-(o-tolylmethyl)-2-[4-(1,2,4-triazol-1-yl)phenyl]benzimidazole;4,6-difluoro-1-[(2-methylphenyl)methyl]-2-[4-(1,2,4-triazol-1-yl)phenyl]benzimidazole
2-[4-(1H-[1,2,4]-triazol-1-yl) phenyl]-1-(2-methylbenzyl)-4,6-difluoro-1H-benzo[d]imidazole化学式
CAS
1163729-07-4
化学式
C23H17F2N5
mdl
——
分子量
401.418
InChiKey
XYYIGZGATLJHPB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    30
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    48.5
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-[4-(1H-[1,2,4]-triazol-1-yl)phenyl]-4,6-difluoro-1H-benzo[d]imidazole2-甲基苄溴 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 1.0h, 以79%的产率得到2-[4-(1H-[1,2,4]-triazol-1-yl) phenyl]-1-(2-methylbenzyl)-4,6-difluoro-1H-benzo[d]imidazole
    参考文献:
    名称:
    SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents
    摘要:
    In the present study, a series of novel 2-[4-(1H-[1,2,4]-triazol-1-yl)phenyl]-1-substituted-4,6-difluoro-1H-benzo[d]imidazole derivatives are synthesized by the alkylation of 2-[4-(1H-[1,2,4]-triazol-1-yl)phenyl]-4,6-difluoro-1H-benzo[d]imidazole with substituted alkyl and aryl halides. The compounds were evaluated for their preliminary in-vitro antibacterial activity against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Salmonella typhosa and then were screened for their antitubercular activity against Mycobacterium tuberculosis H37Rv strain by broth microdilution assay method. The antibacterial data suggested that the analogs with electronegative substituents emerged as promising antimicrobials. It was also observed that the promising antimicrobials have proved to be better antimycobacterials. Few of selected analogs are under further evaluation for secondary antitubercular screening, as they have shown better activity compared to rifampin. (C) 2009 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2008.12.001
点击查看最新优质反应信息

文献信息

  • SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents
    作者:Ganesh Rajaram Jadhav、Mohammad Usman Shaikh、Rajesh Prabhakar Kale、Mahendra Ramesh Shiradkar、Charansingh Harnamsingh Gill
    DOI:10.1016/j.ejmech.2008.12.001
    日期:2009.7
    In the present study, a series of novel 2-[4-(1H-[1,2,4]-triazol-1-yl)phenyl]-1-substituted-4,6-difluoro-1H-benzo[d]imidazole derivatives are synthesized by the alkylation of 2-[4-(1H-[1,2,4]-triazol-1-yl)phenyl]-4,6-difluoro-1H-benzo[d]imidazole with substituted alkyl and aryl halides. The compounds were evaluated for their preliminary in-vitro antibacterial activity against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Salmonella typhosa and then were screened for their antitubercular activity against Mycobacterium tuberculosis H37Rv strain by broth microdilution assay method. The antibacterial data suggested that the analogs with electronegative substituents emerged as promising antimicrobials. It was also observed that the promising antimicrobials have proved to be better antimycobacterials. Few of selected analogs are under further evaluation for secondary antitubercular screening, as they have shown better activity compared to rifampin. (C) 2009 Elsevier Masson SAS. All rights reserved.
查看更多